Source comparison
Sermorelin Sleep Quality Complete Guide 2026: Comparison
Sermorelin (200–300mcg nightly) GHRH receptor agonist. Amplifies endogenous GH pulse during slow-wave sleep Increases delta-wave duration 25–35%; improves sleep efficiency 8–12%; reduces nocturnal awakenings 10–14 days for subjective improvement; polysomnograp
This comparison does not assign a generated winner or score.
- Sermorelin (200–300mcg nightly)
- GHRH receptor agonist. Amplifies endogenous GH pulse during slow-wave sleep
- Increases delta-wave duration 25–35%; improves sleep efficiency 8–12%; reduces nocturnal awakenings
- 10–14 days for subjective improvement; polysomnography changes within 2 weeks
- None. Supports natural pulsatility rather than replacing it
- Best option for users seeking restorative sleep improvement without sedation or next-day impairment. Requires nightly subcutaneous injection and proper reconstitution protocol.
- Melatonin (1–5mg)
- Binds MT1/MT2 receptors in suprachiasmatic nucleus to signal circadian sleep onset
- Reduces sleep latency 7–15 minutes; minimal effect on delta-wave percentage or sleep efficiency
- 30–60 minutes
- None
- Effective for circadian alignment (shift work, jet lag) but does not deepen sleep architecture. Often used incorrectly at excessively high doses (10mg+), which can cause next-day grogginess.
- Exogenous Growth Hormone (2–4 IU nightly)
- Direct GH receptor activation. Bypasses pituitary signalling
- Increases slow-wave sleep in GH-deficient patients; suppresses endogenous GH production via negative feedback
- Immediate GH elevation; sleep changes within days
- High. Long-term use suppresses natural pulsatility and requires medically supervised tapering
- Reserved for diagnosed GH deficiency. Not appropriate for optimization in healthy adults due to receptor downregulation and metabolic side effects (insulin resistance, edema).
- GABA supplements (500–1000mg)
- Intended to increase GABAergic tone. Actual CNS penetration questionable due to blood-brain barrier
- Minimal measurable effect on polysomnography metrics in clinical trials
- Variable; most studies show no objective sleep improvement
- Poor bioavailability across the blood-brain barrier limits efficacy. Subjective effects likely placebo-driven. Consider magnesium glycinate or L-theanine instead for GABAergic support.
- Prescription GHB (Xyrem)
- GABA-B receptor agonist. Directly induces slow-wave sleep
- Dramatic increase in delta-wave sleep (40–60% above baseline); used clinically for narcolepsy
- 15–30 minutes
- High. DEA Schedule III controlled substance with abuse potential
- Effective but tightly regulated. Requires specialized prescribing and patient monitoring. Not comparable to sermorelin due to mechanism and risk profile.